Fernandez Do Porto, D.A., Monteserin, J., Campos, J. et al. Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment. BMC Infect Dis 21, 394 (2021).
https://doi.org/10.1186/s12879-021-06069-9

Pérez-Lago L, Monteserin J, Paul R, et al. Recurrences of multidrug-resistant tuberculosis: Strains involved, within-host diversity, and fine-tuned allocation of reinfections. Transbound Emerg Dis.2022;69:327–336. https://doi.org/10.1111/tbed.13982**
https://doi.org/10.1111/tbed.13982

Zein-Eddine, R., Refrégier, G., Cervantes, J. et al. The future of CRISPR in Mycobacterium tuberculosis infection. J Biomed Sci 30, 34 (2023).
https://doi.org/10.1186/s12929-023-00932-4

Imperiale BR, Gamberale A, Yokobori N, García A, Bartoletti B, Aidar O, et al. Transforming growth factor-β, Interleukin-23 and interleukin-1β modulate TH22 response during active multidrug-resistant tuberculosis. Immunology. 2024;171(1):45–59.
https://doi.org/10.1111/imm.13698

Paul R, Lorenzo F, López B, Alegre M, Couvin D, Rastogi N, et al. Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006–2022. Emerg Infect Dis. 2025;31(3):601-606.
https://doi.org/10.3201/eid3103.241272